These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3780542)

  • 21. Expression of members of the bcl-2 gene family in the immature rat ovary: equine chorionic gonadotropin-mediated inhibition of granulosa cell apoptosis is associated with decreased bax and constitutive bcl-2 and bcl-xlong messenger ribonucleic acid levels.
    Tilly JL; Tilly KI; Kenton ML; Johnson AL
    Endocrinology; 1995 Jan; 136(1):232-41. PubMed ID: 7828536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolactin gene expression and secretion during pregnancy and lactation in the rat: role of dopamine and vasoactive intestinal peptide.
    Escalada J; Cacicedo L; Ortego J; Melian E; Sánchez-Franco F
    Endocrinology; 1996 Feb; 137(2):631-7. PubMed ID: 8593812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-specific regulation of vasoactive intestinal peptide messenger ribonucleic acid levels by estrogen in the rat.
    Kasper S; Popescu RA; Torsello A; Vrontakis ME; Ikejiani C; Friesen HG
    Endocrinology; 1992 Apr; 130(4):1796-801. PubMed ID: 1547709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoactive intestinal peptide-mediated suppression of apoptosis in the ovary: potential mechanisms of action and evidence of a conserved antiatretogenic role through evolution.
    Flaws JA; DeSanti A; Tilly KI; Javid RO; Kugu K; Johnson AL; Hirshfield AN; Tilly JL
    Endocrinology; 1995 Oct; 136(10):4351-9. PubMed ID: 7664654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thyroid hormone regulates vasoactive intestinal peptide (VIP) mRNA levels in the rat anterior pituitary gland.
    Segerson TP; Lam KS; Cacicedo L; Minamitani N; Fink JS; Lechan RM; Reichlin S
    Endocrinology; 1989 Oct; 125(4):2221-3. PubMed ID: 2791988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Localization of vasopressin-, vasoactive intestinal polypeptide-, peptide histidine isoleucine- and somatostatin-mRNA in rat suprachiasmatic nucleus.
    Card JP; Fitzpatrick-McElligott S; Gozes I; Baldino F
    Cell Tissue Res; 1988 May; 252(2):307-15. PubMed ID: 2898292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of the gene and messages for vasoactive intestinal polypeptide (VIP) in rat and mouse.
    Lamperti ED; Rosen KM; Villa-Komaroff L
    Brain Res Mol Brain Res; 1991 Feb; 9(3):217-31. PubMed ID: 1851524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis, cloning and expression in Escherichia coli of artificial genes coding for biologically active elongated precursors of the vasoactive intestinal polypeptide.
    Simoncsits A; Tjörnhammar ML; Kalman M; Cserpan I; Gafvelin G; Bartfai T
    Eur J Biochem; 1988 Dec; 178(2):343-50. PubMed ID: 3145201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stage-specific expression of pituitary adenylate cyclase-activating polypeptide type I receptor messenger ribonucleic acid during ovarian follicle development in the rat.
    Park HJ; Lee J; Wang L; Park JH; Kwon HB; Arimura A; Chun SY
    Endocrinology; 2000 Feb; 141(2):702-9. PubMed ID: 10650952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive intestinal peptide gene expression from embryos to aging rats.
    Gozes I; Schächter P; Shani Y; Giladi E
    Neuroendocrinology; 1988 Jan; 47(1):27-31. PubMed ID: 3340270
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disruption of the optic pathway during development affects vasoactive intestinal peptide mRNA expression.
    Holtzman RL; Malach R; Gozes I
    New Biol; 1989 Nov; 1(2):215-21. PubMed ID: 2488706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sequence of a cDNA encoding chicken vasoactive intestinal peptide (VIP).
    McFarlin DR; Lehn DA; Moran SM; MacDonald MJ; Epstein ML
    Gene; 1995 Mar; 154(2):211-3. PubMed ID: 7890166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-acting analogue of vasoactive intestinal peptide, [R15, 20, 21, L17]-VIP-GRR (IK312532), protects rat alveolar L2 cells from the cytotoxicity of cigarette smoke.
    Onoue S; Endo K; Ohmori Y; Yamada S; Kimura R; Yajima T; Kashimoto K
    Regul Pept; 2004 Dec; 123(1-3):193-9. PubMed ID: 15518912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nucleotide sequence divergence and functional constraint in VIP precursor mRNA evolution between human and rat.
    Nishizawa M; Hayakawa Y; Yanaihara N; Okamoto H
    FEBS Lett; 1985 Apr; 183(1):55-9. PubMed ID: 3838518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vasoactive intestinal peptide can promote the development of neonatal rat primordial follicles during in vitro culture.
    Chen N; Li Y; Wang W; Ma Y; Yang D; Zhang Q
    Biol Reprod; 2013 Jan; 88(1):12. PubMed ID: 23175772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coding sequences for vasoactive intestinal peptide and PHM-27 peptide are located on two adjacent exons in the human genome.
    Bodner M; Fridkin M; Gozes I
    Proc Natl Acad Sci U S A; 1985 Jun; 82(11):3548-51. PubMed ID: 2987932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Location of PHM/VIP mRNA in human gastrointestinal tract detected by in situ hybridization.
    Bredkjaer HE; Wulff BS; Emson PC; Fahrenkrug J
    Cell Tissue Res; 1994 May; 276(2):229-38. PubMed ID: 8020060
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of vasoactive intestinal polypeptide receptor mRNA and secretory regulation by vasoactive intestinal polypeptide in rat submandibular and sublingual salivary glands.
    Takai N; Yoshida Y; Shida T; Kondo E; Ueda Y; Kiyama H; Tohyama M
    Arch Oral Biol; 1997 Mar; 42(3):197-204. PubMed ID: 9188989
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VPAC2 receptors mediate vasoactive intestinal peptide-induced neuroprotection against neonatal excitotoxic brain lesions in mice.
    Rangon CM; Goursaud S; Medja F; Lelièvre V; Mounien L; Husson I; Brabet P; Jégou S; Janet T; Gressens P
    J Pharmacol Exp Ther; 2005 Aug; 314(2):745-52. PubMed ID: 15872042
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternatively polyadenylated vasoactive intestinal peptide mRNAs are differentially regulated at the level of stability.
    Chew LJ; Murphy D; Carter DA
    Mol Endocrinol; 1994 May; 8(5):603-13. PubMed ID: 7520128
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.